CollPlant Biotechnologies (CLGN) Balance Sheet: Assets & Liabilities

CollPlant Biotechnologies (CLGN) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), CollPlant Biotechnologies reported total assets of $10.79M and total liabilities of $4.70M. Shareholders' equity was $6.08M, down 54.8% from $13.46M a year earlier. Total debt stood at $2.85M against $5.59M in cash and short-term investments, a net cash position of $2.75M. That puts debt-to-equity at 0.47, compared with 0.23 a year earlier.

CollPlant Biotechnologies Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for CollPlant Biotechnologies Ltd. (CLGN) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Mar 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Mar 2020	Mar 2019	Dec 2017
Current Assets
Cash and Cash Equivalents	5.59	11.91	26.67	26.67	29.65	13.15	3.33	3.79	5.33	5.13
Short-Term Investments	0.00	0.00	0.00	-	0.00	30.15	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	5.59	11.91	26.67	26.67	29.65	43.30	3.33	3.79	5.33	5.13
Accounts Receivable	0.00	0.15	0.39	0.39	0.01	0.27	0.83	0.08	0.52	0.10
Inventory	0.57	0.44	0.71	0.71	1.43	1.08	1.26	0.89	0.81	0.20
Other Current Assets	0.22	0.25	0.24	0.63	0.57	0.44	0.25	0.28	0.49	1.02
Total Current Assets	6.75	13.18	28.02	28.02	31.66	45.09	5.68	5.04	7.14	6.45
Non-Current Assets
Property, Plant & Equipment (Net)	3.89	5.28	5.86	5.86	5.68	5.68	4.90	5.54	1.40	1.03
Long-Term Investments	0.08	0.12	0.06	-	0.19	0.00	0.18	0.17	0.17	0.17
Intangible Assets	0.07	0.13	0.19	0.19	0.25	0.24	0.08	0.00	0.34	0.42
Other Non-Current Assets	0.08	0.12	0.00	0.06	0.19	0.21	0.18	0.00	0.17	0.17
Total Non-Current Assets	4.04	5.53	6.10	6.10	6.11	6.14	5.17	5.71	1.91	1.62
Total Assets	10.79	18.71	34.13	34.13	37.77	51.22	10.84	10.75	9.05	8.07
Current Liabilities
Accounts Payable	0.61	0.87	0.98	0.98	1.13	1.03	0.80	0.83	0.62	0.84
Short-Term Debt	0.81	0.81	0.62	-	0.53	0.52	0.44	0.48	0.02	0.00
Accrued Liabilities	1.25	0.10	-	1.65	0.94	0.86	1.94	-	-	-
Deferred Revenue	0.00	0.00	0.00	-	0.00	0.03	0.21	0.94	0.97	0.00
Other Current Liabilities	1.25	1.29	1.65	-	1.44	1.43	1.94	1.20	0.63	0.57
Total Current Liabilities	2.67	2.97	3.25	3.25	3.11	3.01	3.39	3.46	2.23	1.42
Non-Current Liabilities
Long-Term Debt	2.03	2.28	2.54	2.54	2.38	3.09	2.95	3.14	0.02	3.64
Deferred Tax Liabilities	0.00	0.00	0.00	-	0.00	0.00	0.00	0.00	0.74	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	-	0.00	0.00	0.03	0.07	1.08	0.40
Total Non-Current Liabilities	2.03	2.28	2.54	2.54	2.38	3.09	2.98	3.21	2.05	4.04
Total Liabilities	4.70	5.25	5.79	5.79	5.49	6.10	6.36	6.66	4.29	5.46
Stockholders' Equity
Common Stock	5.49	4.98	4.98	4.98	4.87	4.66	2.93	2.37	1.52	1.44
Retained Earnings	-124.84	-113.35	-96.74	-96.74	-89.72	-72.80	-73.03	-67.26	-49.03	-50.17
Accumulated Other Comprehensive Income	-0.97	-0.97	-0.97	-0.97	-0.97	-0.97	-0.97	-0.97	-2.84	-2.70
Additional Paid-in Capital	126.40	122.80	121.07	121.07	118.10	114.22	75.55	69.95	60.91	47.87
Shares Outstanding	12.80	11.45	-	11.45	11.19	10.77	-	-	-	-
Total Stockholders' Equity	6.08	13.47	28.34	28.34	32.28	45.12	4.48	4.09	4.76	2.61
Total Liabilities & Equity	10.79	18.71	34.13	34.13	37.77	51.22	10.84	10.75	9.05	8.07

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About CollPlant Biotechnologies Balance Sheet

How much debt does CollPlant Biotechnologies have?

CollPlant Biotechnologies had total debt of $2.85M as of Dec 31, 2025, against $5.59M in cash and short-term investments. Its debt-to-equity ratio was 0.47. Total debt was $3.08M a year earlier.

What are CollPlant Biotechnologies's total assets?

CollPlant Biotechnologies reported total assets of $10.79M as of Dec 31, 2025, down 42.4% from $18.71M a year earlier. Total liabilities were $4.70M.

What is CollPlant Biotechnologies's shareholders' equity?

CollPlant Biotechnologies's shareholders' equity was $6.08M as of Dec 31, 2025, or about $0.47 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition